Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Lugosi

Showing results (1-10 of 33) with videos related to

Pageof 4
Sort By:
Acta Microbiologica Hungarica|January 1, 1987
Stability of the Hungarian National BCG Reference Preparations. Trend of viability during 4-7 years storage at +4 degrees CL Lugosi
Vaccine|June 1, 1984
Multiple comparison of dried BCG vaccines: stability at 37 degrees C and persistence of strains in the mouse spleenL Lugosi
Orvosi Hetilap|March 26, 1972
[BCG and immunotherapy for tumors. Prevention of adverse effects of BCG vaccination]L Lugosi
Bulletin of the International Union Against Tuberculosis|January 1, 1974
[Data on BCG vaccination and the evolutionary tendency of tuberculosis in children in Hungary since 1959, a country in which economic development has reached an intermediate level and where a contrast exists between childhood and adult tuberculosis]L Lugosi
Developments in Biological Standardization|January 1, 1986
BCG policy and tuberculosis control in HungaryL Lugosi
Developments in Biological Standardization|January 1, 1992
Standardized viability test required for preventive, immunomodulator and recombinant BCG vaccineL Lugosi
International Journal of Epidemiology|June 1, 1985
Trends in childhood tuberculosis in Hungary 1953-1983: quantitative methods for evaluation of BCG policyL Lugosi
Vaccine|April 1, 1990
Analysis of variables of plasmid transformation of a bacterial vaccine: studies on recombinant BCGL Lugosi
Annales De Microbiologie|November 1, 1982
[Stability of the viability of the dried BCG vaccine (Pasteur strain 1173-P2) stored at 4 degrees C for 540 days: a statistical study]L Lugosi
Tubercle and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|October 1, 1992
Theoretical and methodological aspects of BCG vaccine from the discovery of Calmette and Guérin to molecular biology. A reviewL Lugosi
Pageof 4

Showing results (1-10 of 33) with videos related to

Sort By:
Pageof 4
Acta Microbiologica Hungarica|January 1, 1987
Stability of the Hungarian National BCG Reference Preparations. Trend of viability during 4-7 years storage at +4 degrees CL Lugosi
Vaccine|June 1, 1984
Multiple comparison of dried BCG vaccines: stability at 37 degrees C and persistence of strains in the mouse spleenL Lugosi
Orvosi Hetilap|March 26, 1972
[BCG and immunotherapy for tumors. Prevention of adverse effects of BCG vaccination]L Lugosi
Bulletin of the International Union Against Tuberculosis|January 1, 1974
[Data on BCG vaccination and the evolutionary tendency of tuberculosis in children in Hungary since 1959, a country in which economic development has reached an intermediate level and where a contrast exists between childhood and adult tuberculosis]L Lugosi
Developments in Biological Standardization|January 1, 1986
BCG policy and tuberculosis control in HungaryL Lugosi
Developments in Biological Standardization|January 1, 1992
Standardized viability test required for preventive, immunomodulator and recombinant BCG vaccineL Lugosi
International Journal of Epidemiology|June 1, 1985
Trends in childhood tuberculosis in Hungary 1953-1983: quantitative methods for evaluation of BCG policyL Lugosi
Vaccine|April 1, 1990
Analysis of variables of plasmid transformation of a bacterial vaccine: studies on recombinant BCGL Lugosi
Annales De Microbiologie|November 1, 1982
[Stability of the viability of the dried BCG vaccine (Pasteur strain 1173-P2) stored at 4 degrees C for 540 days: a statistical study]L Lugosi
Tubercle and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|October 1, 1992
Theoretical and methodological aspects of BCG vaccine from the discovery of Calmette and Guérin to molecular biology. A reviewL Lugosi
Pageof 4